PAM
REVBU

Panagora Asset Management’s Revelation Biosciences, Inc. Unit REVBU Stock Holding History

Panagora Asset Management’s Portfolio REVBU Stock Details REVBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,931
Closed -$86K – 2980
2020
Q4 		$86K Buy
+7,931
New +$80.5K ﹤0.01% 1895

Other funds holding REVBU

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
CFN
Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Panagora Asset Management's REVBU Position: Q1 2021 in Review

Panagora Asset Management sold out of Revelation Biosciences, Inc. Unit (REVBU) in Q1 2021, closing a stake of 7,931 shares — an estimated $86K sold.

Panagora Asset Management first reported a position in REVBU in Q4 2020 and held it in 1 quarter. The position peaked at $86K in Q4 2020. 4 funds tracked by Wall St. Rank hold REVBU as of Q1 2021.

  • Panagora Asset Management reported no remaining Revelation Biosciences, Inc. Unit position as of Q1 2021 after selling out during the quarter.
  • Panagora Asset Management sold 7,931 Revelation Biosciences, Inc. Unit shares in Q1 2021, an estimated $86K.
  • Panagora Asset Management first reported a position in Revelation Biosciences, Inc. Unit in Q4 2020 and held it in 1 quarter.
  • Panagora Asset Management's Revelation Biosciences, Inc. Unit position peaked at $86K in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Revelation Biosciences, Inc. Unit as of Q1 2021.

Based on Panagora Asset Management's 13F filing for Q1 2021, filed 12 May 2021.